Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...

A new technical paper, “Neural Computers,” was published by researchers at Meta AI and KAUST. Abstract “We propose a new ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...